Identification of Optimal Subcutaneous Doses of Tocilizumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis

被引：0

作者：

Brunner, Hermine ^{[1
]}

Ruperto, Nicola ^{[2
]}

Martini, Alberto ^{[2
]}

Ramanan, Athimalaipet ^{[3
]}

Cuttica, Ruben ^{[4
]}

Weiss, Jennifer E. ^{[5
]}

Henrickson, Michael ^{[6
]}

Schmeling, Heinrike ^{[7
]}

Anton, Jordi ^{[8
]}

Minden, Kirsten ^{[9
]}

Hsu, Joy ^{[10
]}

Bharucha, Kamal ^{[11
]}

Wimalasundera, Sunethra ^{[12
]}

Kadva, Alysha K. ^{[13
]}

Upmanyu, Ruchi ^{[12
]}

Mallalieu, Navita L. ^{[10
]}

Lovell, Daniel ^{[6
]}

De Benedetti, Fabrizio ^{[14
]}

机构：

[1] PRCSG, Rheumatol, Cincinnati, OH USA

[2] PRINTO Coordinating Ctr, Genoa, Italy

[3] Bristol Royal Hosp Children, Bristol, Avon, England

[4] Hosp Gral Ninos Pedro Elizalde, Buenos Aires, DF, Argentina

[5] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[6] Cincinnati Childrens Hosp Med Ctr, PRCSG, Cincinnati, OH 45229 USA

[7] Univ Calgary, Alberta Childrens Hosp, Calgary, AB, Canada

[8] Hosp St Joan de Deu, Barcelona, Spain

[9] Charite, Berlin, Germany

[10] Roche Innovat Ctr, New York, NY USA

[11] Genentech Inc, San Francisco, CA 94080 USA

[12] Roche Prod Ltd, Welwyn Garden City, Herts, England

[13] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA

[14] IRCCS Osped Pediat Bambino Gesu, Rome, Italy

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：59 / 60

页数：2

共 50 条

[31] Long-Term Safety of Subcutaneous Tocilizumab Administration in Systemic and Polyarticular Juvenile Idiopathic Arthritis
Brunner, Hermine I.
Ruperto, Nicola
Martini, Alberto
Ramanan, Athimalaipet V.
Cuttica, Ruben J.
Weiss, Jennifer E.
Henrickson, Michael
Schmeling, Heinrike
Anton, Jordi
Minden, Kirsten
Horneff, Gerd
Luz Gamir-Gamir, Maria
Hufnagel, Markus
Douglass, Wendy
Wells, Chris
Wimalasundera, Sunethra
Mallalieu, Navita L.
Lovell, Daniel J.
De Benedetti, Fabrizio
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[32] Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial
Brunner, Hermine I.
Ruperto, Nicolino
Zuber, Zbigniew
Cuttica, Ruben
Keltsev, Vladimir
Xavier, Ricardo M.
Burgos-Vargas, Ruben
Penades, Inmaculada Calvo
Silverman, Earl D.
Espada, Graciela
Zavaler, Manuel Ferrandiz
Kimura, Yukiko
Duarte, Carolina
Job-Deslandre, Chantal
Joos, Rik
Douglass, Wendy
Wimalasundera, Sunethra
Bharucha, Kamal N.
Wells, Chris
Lovell, Daniel J.
Martini, Alberto
de Benedetti, Fabrizio
[J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (03) : 530 - 541
[33] SAFETY AND EFFICACY OF TOCILIZUMAB IN METHOTREXATE-RESISTANT FORM OF POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS: FACTORS ASSOCIATED WITH ACHIEVEMENT OF INACTIVE DISEASE STATUS
Kostik, M. M.
Chikova, I. A.
Isupova, E. A.
Masalova, V. V.
Dubko, M. F.
Likhacheva, T. S.
Snegireva, L. S.
Kalashnikova, O. V.
Chasnyk, V. G.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 619 - 619
[34] Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial
Bharucha, Kamal N.
Brunner, Hermine I.
Calvo Penades, Inmaculada
Nikishina, Irina
Rubio-Perez, Nadina
Oliveira, Sheila
Kobusinska, Katarzyna
Schmeling, Heinrike
Sztajnbok, Flavio
Weller-Heinemann, Frank
Zholobova, Elena
Zulian, Francesco
Allen, Roger
Chaitow, Jeffrey
Frane, James
Wells, Chris
Ruperto, Nicolino
De Benedetti, Fabrizio
[J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (08) : 1173 - 1179
[35] Patient-Reported Outcomes in Children with Moderately to Severely Active Polyarticular or Polyarticular-Course Juvenile Idiopathic Arthritis Who Are Prescribed and Treated with Adalimumab.
Horneff, Gerd
Wallace, Carol A.
Quartier, Pierre
Kingsbury, Daniel J.
Minden, Kirsten
Bereswill, Mareike
Garg, Vishvas
Kupper, Hartmut
Kalabic, Jasmina
[J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S122 - S123
[36] TOCILIZUMAB THERAPY IN CHILDREN WITH POLYARTHICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS
Alexeeva, E.
Denisova, R.
Valieva, S.
Bzarova, T.
Isayeva, K.
Sleptsova, T.
Chistyakova, E.
Chomahidze, A.
Lomakina, O.
Soloshenko, M.
Fetisova, A.
Kashchenko, E.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 765 - 765
[37] TOCILIZUMAB THERAPY IN CHILDREN WITH POLYARTHICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS
Alexeeva, E.
Denisova, R.
Valieva, S.
Bzarova, T.
Kseniya, I.
Sleptsova, T.
Chistyakova, E.
Chomakhidze, A.
Soloshenko, M.
Fetisova, A.
Lomakina, O.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 383 - 383
[38] Bridging from the Intravenous to Subcutaneous Formulation of Tocilizumab for Polyarticular Juvenile Idiopathic Arthritis and Systemic Juvenile Idiopathic Arthritis by Leveraging Prior Pharmacometrics Knowledge
Hsu, Joy C.
Gibiansky, Leonid
Bharucha, Kamal
Kadva, Alysha
Kamal, Mohamed
Mallalieu, Navita
Frey, Nicolas
[J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S104 - S104
[39] Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial
Vilca, Iris
Munitis, Pablo Garcia
Pistorio, Angela
Ravelli, Angelo
Buoncompagni, Antonella
Bica, Blanca
Campos, Lucia
Haefner, Renate
Hofer, Michael
Ozen, Seza
Huemer, Christian
Bae, Sang Cheol
Sztajnbok, Flavio
Arguedas, Olga
Foeldvari, Ivan
Huppertz, Hans Iko
Luz Gamir, Maria
Magnusson, Bo
Dressler, Frank
Uziel, Yosef
van Rossum, Marion A. J.
Hollingworth, Peter
Cawkwell, Gail
Martini, Alberto
Ruperto, Nicolino
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1479 - 1483
[40] Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis
Lovell, DJ
Reiff, A
Jones, OY
Schneider, R
Nocton, J
Stein, LD
Gedalia, A
Ilowite, NT
Wallace, CA
Whitmore, JB
White, B
Giannini, EH
[J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (06): : 1987 - 1994

← 1 2 3 4 5 →